
Breakthrough “Closed Loop” Technology Changes the Landscape for State Human Services Programs
Gerard Scimeca Chairman, CASE March 9, 2023 Though it may be impossible to pinpoint exactly when our current digital...
Gerard Scimeca Chairman, CASE March 9, 2023 Though it may be impossible to pinpoint exactly when our current digital...
February 3, 2023 It’s not your grandparents’ AARP anymore. Whether it’s their celebration of the Inflation Reduction Act or historical support of Obamacare,...
January 25, 2023 Make no mistake, Congress and the Biden administration took a sledgehammer to the American healthcare system...
January 18, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE) sent a letter to high-level...
December 4, 2022 The senators’ mention of pharmacy services was especially interesting, given the recent cut of pharmacy services...
November 7, 2022 The 340B program, a flawed plan that allows hospitals to steal savings meant for low-income patients,...
Military members, veterans, and their families are devastated by Express Scripts dropping nearly 15,000 local and independent pharmacies to boost...
October 23, 2022 In a desperate attempt to reshape the narrative, President Biden hosted a celebration last month for...
October 10, 2022 With the backing of President Biden, the World Trade Organization (WTO) has taken steps to tear down...
August 18, 2022 Gerard Scimeca Chairman, CASE As President Biden and Democrats celebrate their reconciliation “victory,” American patients are...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers